Literature DB >> 24415281

Nonalcoholic fatty liver disease in morbidly obese subjects: correlation among histopathologic findings, biochemical features, and ultrasound evaluation.

Everton Cazzo1, Fabio de Felice Gallo, José Carlos Pareja, Elinton Adami Chaim.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) has become an important health issue lately. The aim of this study is to determine its prevalence among obese subjects which undergo Roux-en-Y gastric bypass (RYGB). It is a cross-sectional retrospective study involving 164 subjects who underwent RYGB. Clinical, biochemical, and histopathologic features were evaluated. The most common histopathologic features observed were steatohepatitis with fibrosis (29.9 %) and isolated fibrosis (29.3 %). Increased alkaline phosphatase was associated to NAFLD. Dyslipidemia and type 2 diabetes mellitus were associated to NAFLD. Ultrasound had a global accuracy of 78 % to detect NAFLD. Higher prevalence of severe forms of NAFLD was observed compared to previous reports. Most routine biochemical studies had poor correlation with NAFLD and ultrasound was useful but not definitive to detect NAFLD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24415281     DOI: 10.1007/s11695-014-1183-4

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  20 in total

1.  Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement.

Authors: 
Journal:  Am J Clin Nutr       Date:  1992-02       Impact factor: 7.045

Review 2.  Can NASH be diagnosed, graded, and staged noninvasively?

Authors:  Garfield A Grandison; Paul Angulo
Journal:  Clin Liver Dis       Date:  2012-06-26       Impact factor: 6.126

3.  Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.

Authors:  Camilo Boza; Arnoldo Riquelme; Luis Ibañez; Ignacio Duarte; Enrique Norero; Paola Viviani; Alejandro Soza; Jose Ignacio Fernandez; Alejandro Raddatz; Sergio Guzman; Marco Arrese
Journal:  Obes Surg       Date:  2005-09       Impact factor: 4.129

4.  Prevalence of liver steatosis and fibrosis and the diagnostic accuracy of ultrasound in bariatric surgery patients.

Authors:  Jiang Wu; Jing You; Lisa Yerian; Ayako Shiba; Philip R Schauer; Daniel I Sessler
Journal:  Obes Surg       Date:  2012-02       Impact factor: 4.129

Review 5.  Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.

Authors:  Kenneth Cusi
Journal:  Gastroenterology       Date:  2012-02-08       Impact factor: 22.682

6.  Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.

Authors:  Jeanne M Clark; Amir R A Alkhuraishi; Steven F Solga; Patricia Alli; Anna Mae Diehl; Thomas H Magnuson
Journal:  Obes Res       Date:  2005-07

7.  Prevalence of nonalcoholic fatty liver disease (NAFLD) and utility of FIBROspect II to detect liver fibrosis in morbidly obese Hispano-American patients undergoing gastric bypass.

Authors:  Gustavo Eugenio Guajardo-Salinas; Ashraf Hilmy
Journal:  Obes Surg       Date:  2009-12-03       Impact factor: 4.129

Review 8.  The impact of bariatric surgery on nonalcoholic fatty liver disease.

Authors:  Alexandre Coutinho Teixeira de Freitas; Antonio Carlos Ligocki Campos; Julio Cezar Uili Coelho
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-05       Impact factor: 4.294

Review 9.  Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.

Authors:  Elisa Fabbrini; Shelby Sullivan; Samuel Klein
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

10.  The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.

Authors:  Sherene Shalhub; Anna Parsee; Scott F Gallagher; Krista L Haines; Chris Willkomm; Stephen G Brantley; Haim Pinkas; Lisa Saff-Koche; Michel M Murr
Journal:  Obes Surg       Date:  2004-01       Impact factor: 4.129

View more
  4 in total

1.  Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study.

Authors:  Everton Cazzo; Laísa Simakawa Jimenez; José Carlos Pareja; Elinton Adami Chaim
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

2.  The Correlation Between Obesity-Related Diseases and Non-alcoholic Fatty Liver Disease in Women in the Pre-operative Evaluation for Bariatric Surgery Assessed by Transient Hepatic Elastography.

Authors:  Fernando de Barros; Sérgio Setúbal; José Manoel Martinho; Nathalie Carvalho Leite; Thais Guaraná; Ana Beatriz Soares Monteiro; Cristiane A Villela-Nogueira
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

3.  A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.

Authors:  G Craig Wood; Xin Chu; George Argyropoulos; Peter Benotti; David Rolston; Tooraj Mirshahi; Anthony Petrick; John Gabrielson; David J Carey; Johanna K DiStefano; Christopher D Still; Glenn S Gerhard
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

4.  Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.

Authors:  Philippe Garteiser; Laurent Castera; Muriel Coupaye; Sabrina Doblas; Daniela Calabrese; Marco Dioguardi Burgio; Séverine Ledoux; Pierre Bedossa; Marina Esposito-Farèse; Simon Msika; Bernard E Van Beers; Pauline Jouët
Journal:  JHEP Rep       Date:  2021-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.